| DTI | Bi-exponential model | Tri-exponential model | ||||
---|---|---|---|---|---|---|---|
MD [10−3 mm2/s] | FA | fstar [%] | Dbi [10−3 mm2/s] | ffast [%] | finterm [%] | Dtri [10−3 mm2/s] | |
cc-RCC (n = 9) | 1.94 (0.33) | 0.46 (0.12 | 11.6 (3.62) | 1.71 (0.42) | 7.36 (3.14) | 18.8 (5.78) | 1.38 (0.34) |
cc-RCC with sarcoid differentiation, extensive necrosis and hemorrhaging (n = 1) | 1.77 | 0.58 | 12.5 | 1.38 | 7.83 | 20.1 | 1.04 |
cc-RCC with extensive necrosis (n = 1) | 1.19 | 0.64 | 10.78 | 0.92 | 6.13 | 15.11 | 0.71 |
cc-RCC with papillary growth (n = 1) | 1.82 | 0.28 | 16.5 | 1.49 | 11.2 | 20.6 | 1.19 |
cc-RCC with cells situated in nests and extravasation of erythrocytes (n = 1) | 1.94 | 0.40 | 14.29 | 1.71 | 9.11 | 22.25 | 1.71 |
cc-RCC with areas of low cell density, hemorrhaging and cystic structures (n = 1) | 2.24 | 0.57 | 10.35 | 1.90 | 6.22 | 12.46 | 1.68 |
cc-RCC with extensive hemorrhage (n = 1) | 2.01 | 0.46 | 16.62 | 1.71 | 12.43 | 16.09 | 1.49 |
cc-RCC with cystic and solid areas (n = 1) | 2.20 | 0.45 | 8.69 | 1.97 | 6.25 | 15.31 | 1.69 |
cc-RCC with micro- cystic structures and hemorrhaging (n = 1) | 2.17 | 0.36 | 7.95 | 2.39 | 2.83 | 31.72 | 1.68 |
p-RCC (n = 2) | 1.68 (0.20) | 0.50 (0.01) | 11.3 (3.8) | 1.36 (0.06) | 6.56 (1.80) | 16.3 (2.88) | 1.14 (0.06) |
Hemangioma (n = 1) | 2.38 | 0.61 | 6.06 | 2.45 | 2.99 | 22.6 | 1.99 |
Oncocytoma (n = 1) | 1.98 | 0.34 | 17.1 | 1.63 | 12.5 | 19.2 | 1.36 |